Table 2.
Measurement | CTRL (n = 11) | JUMP (n = 12) | Statistics | ||||
---|---|---|---|---|---|---|---|
Pre | Post | Pre | Post | Time | Int | T*Int | |
Glucose0 (mmol/L) | 5.18 ± 0.40 | 5.24 ± 0.51 | 5.32 ± 0.64 | 5.47 ± 0.59 | 0.447 | 0.311 | 0.732 |
Glucose120 (mmol/L) | 6.95 ± 1.01 | 8.51 ± 1.80 | 7.36 ± 1.82 | 7.98 ± 1.98 | 0.010 | 0.919 | 0.234 |
Insulin0 (pmol/L) | 45.00 ± 13.09 | 51.48 ± 16.49 | 55.55 ± 14.92 | 67.22 ± 19.14 | 0.012 | 0.036 | 0.437 |
Insulin120† (pmol/L) | 347.16 ± 184.12 | 496.38 ± 321.36 | 468.39 ± 281.21 | 492.68 ± 260.41 | 0.054 | 0.587 | 0.264 |
NEFA (mmol/L) | 0.40 ± 0.13 | 0.41 ± 0.16 | 0.41 ± 0.14 | 0.52 ± 0.17 | 0.124 | 0.232 | 0.215 |
TG (mmol/L) | 0.87 ± 0.26 | 1.00 ± 0.26 | 1.16 ± 0.45 | 1.21 ± 0.41 | 0.013 | 0.102 | 0.245 |
CHOL (mmol/L) | 4.09 ± 0.72 | 4.27 ± 0.86 | 4.11 ± 0.57 | 4.06 ± 0.57 | 0.619 | 0.710 | 0.381 |
HDL (mmol/L) | 1.16 ± 0.17 | 0.99 ± 0.19 | 1.08 ± 0.27 | 0.91 ± 0.17 | <0.001 | 0.304 | 0.955 |
LDL (mmol/L) | 2.76 ± 0.71 | 3.10 ± 0.71 | 2.73 ± 0.51 | 2.99 ± 0.56 | 0.004 | 0.780 | 0.647 |
Data are presented as mean ± standard deviation (SD). Significant p < 0.05 are indicated in bold. †Denotes that data were transformed for statistical analysis. Metabolic characteristics were measured on BDC-5 and HDT59. CTRL, control group; JUMP, jumping countermeasure group; Time, main effect of time; Int, main effect of intervention; T*Int, time*intervention interaction effect; Glucose0, fasting glucose; Glucose120, glucose concentrations 120 min after the glucose load; Insulin0, fasting insulin; Insulin120, insulin concentrations 120 min after the glucose load; NEFA, non-esterified fatty acids; TG, triglycerides; CHOL, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol.